The advantages of this study consist of the selection criteria (patients without chemotherapy and without initial infectious focus and confirmed during follow-up) that allowed us to identify the association of HMGB1, IL-8, IL-10, IL1-β, and MCP-1 with leukemic activity and the generation of SIRS. The gene discussed is CCL2; the disease is systemic inflammatory response syndrome.